Malaria prophylaxis timing — DTM&H MCQ

Correct answer: D — 1-2 days before departure

The correct answer is D, 1-2 days before departure. Atovaquone-proguanil (Malarone) is unique among the standard UK prophylactic regimens because it has causal activity against the pre-erythrocytic (liver) stage of Plasmodium, so it does not need to be built up to steady state over weeks like mefloquine or doxycycline. Because of this mechanism, the UK-licensed dosing schedule requires starting only 1-2 days before entering the malaria-endemic area, continuing daily throughout the stay, and stopping just 7 days after return, giving the shortest total course of any first-line agent. This short pre-travel lead-in also makes it the preferred choice for late-notice travellers, such as a student finalising a trip to rural monsoon-season India where malaria risk (including chloroquine-resistant falciparum) is significant. Why the other options are wrong: A, 4 weeks before departure: This is the schedule for mefloquine, which needs early initiation to assess tolerability (neuropsychiatric side effects) and reach steady-state plasma levels, not required for atovaquone-proguanil. B, 2 weeks before departure: No standard UK antimalarial requires a 2-week pre-travel start; doxycycline needs only 1-2 days before travel, and atovaquone-proguanil the same, so this interval does not apply to any first-line regimen. D, On arrival in the endemic area: Starting only on arrival leaves no protective drug level in the blood at the point of first mosquito exposure, risking early inoculation before prophylactic cover is established. E, Only if she develops malaria symptoms: Prophylaxis is preventive, not treatment-triggered; waiting for symptoms defeats the purpose and delays killing liver-stage parasites before they cause clinical disease. Key point: Atovaquone-proguanil's causal (liver-stage) activity allows the shortest pre-travel start of just 1-2 days, unlike mefloquine's 2-3 week lead-in.

Reference: BNF (NICE), Antimalarials, Atovaquone with proguanil hydrochloride, prophylaxis dosing; electronic Medicines Compendium (emc), Malarone Summary of Product Characteristics, Posology section, https://www.medicines.org.uk/emc/product/114